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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S155smoothing of the articular cartilage contours. The T2 map data of all
patients indicate mild shortening of the values, especially at the scaf-
folding edges and the deepest layers, which suggests early organization of
the allograft. Thus far, no patient studied at 6 months has worsening pain
or clinical scores relative to the pre-operative and 3month time points. At
the 9 month time point, seven patients (N ¼ 7) have stable or improved
morphological and thickness map data, as well as further decreasing T2
values; the zones of T2 shortening in these patients have broadened. One
patient (N ¼ 1) at nine months has slight thinning of the allograft ﬁll
morphologically and on the segmented thickness maps; this patient’s T2
values are stable (Fig 1). All patients at nine months have either stable or
improved pain and function scores.
Conclusion: Initial results indicate that MRI morphological and quanti-
tative data can be used to monitor patients who are post-allograft repair.
Obviously,more longitudinal data are needed to verify the utility ofMRI as
a biomarker for allograft repair success or failure. Future work also will
include fusing thickness map and T2 data, so as to display optimally
quantitative data, in intuitive, clinically useful renderings (Fig. 2).Fig 1. Tosp left image is a sagittal image of a patient with a large, discrete
AC defect of the medial femoral condyle. The top right image is of the
same patient six months post allograft repair; the image shows good
allograft material ﬁll in the prior defect. The bottom image is a multi-echo
T2 Map of the same patient six months post allograft repair. The T2 Map,
acquired during the same six month scanning session demonstrates early
AC incorporation and organization.
Fig 2. T2 data is fused to 3D thickness map derived from automated
segmentation to generate a 3D T2 Map. Courtesy: Jose Tamez-Pena254
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Introduction: Surgical management of large, full-thickness osteo-
chondral defects of the knee in young to middle-aged patients poses
a difﬁcult problem for orthopaedic surgeons. Full-thickness articular
cartilage defects are common in young active patients, many of
which do not have underlying alignment issues. Without inter-
vention, these osteochondral lesions will continue to cause pain
indeﬁnitely, and typically progress to global joint degeneration due
to the limited intrinsic healing capacity of cartilage. Fresh osteo-
chondral allograft transplantation is a suitable treatment option for
these larger chondral defects, especially transplantation of fresh
osteochondral allografts. Although fresh osteochondral allograft
transplantation has become an increasingly popular technique for
osteochondral repair, donor site morbidity and unpredictable obsta-
cles can create longer wait times for patients undergoing
transplantation.
An alternative allograft has been developed, addressing the current
drawbacks associated with fresh osteochondral allograft usage.
Chondroﬁx Osteochondral Allograft (Zimmer, Austin, USA) is a de-
cellularized, osteochondral graft of hyaline cartilage and cancellous
bone. Chondroﬁx has been terminally sterilized and virus-inacti-
vated with low dose gamma irradiation (15 -18 kGy) at low temper-
atures (below 0C). Further processing includes chemical lipid
extraction of the allograft in an effort to decrease incorporation time.
Chondroﬁx is currently being used to resurface osteochondral
lesions in the knee, however, to our knowledge, there are no reports
providing gross in situ examination of the osteochondral allograft
following implantation. This article reports a unique situation in
which a Chondroﬁx allograft plug is inserted and subsequently
arthroscopically evaluated at 18 and 25months post-implantation in a
patient undergoing concomitant ACL reconstruction and medial
meniscal allograft transplantation.
Case report: At the time of injury, the patient was a 16-year-old com-
petitive soccer player who suffered an ACL rupture as well as a large
medial femoral condyle OCD (1.6 cm x 1.5 cm) and concomitant medial
meniscal tear during play. He was initially treated with an allograft
hamstring ACL reconstruction and Chondroﬁx osteochondral allograft
implantation as well as medial meniscectomy. However, at 18 months
postoperatively, he re-ruptured his ACL and suffered further tearing of
his medial meniscus requiring revision ACL reconstruction and menis-
cal allograft transplantation. The Chondroﬁx allograft was evaluated
at this time and found to be healed and rigidly incorporated in the host
condyle. Minimal demarcation, with smooth borders and appropriate
contour could be seen between the chondral surface of the host and the
allograft. Additionally, little to no wear was noted on the opposing
cartilage surface. After return to sport 25 months post implantation of
the Chondroﬁx allograft, the patient, again, re-ruptured his ACL
requiring a staged revision reconstruction. Again, the allograft plug was
evaluated. At over two years since placement, gross examination
revealed difﬁculty in identifying distinct borders. Further, probing of
the articular allograft cartilage was consistent with the patients’ native
tissue.
Discussion: Our unique case report demonstrates a rare second and
subsequently third look 25 months after initial implantation of a
Chondroﬁx graft in a young athlete. Upon examination, the graft
demonstrated complete bony incorporation with undetected articu-
lar cartilage margins, and restoration of native femoral condylar
radius of curvature. These results were found despite an extremely
suboptimal healing environment; the patient underwent multiple
operations, he had a signiﬁcant meniscal tear eventually requiring
allograft transplantation, and he was, at times, devoid of an ACL for
many months.
Full-thickness osteochondral defects in young patients can be managed
surgically, and Chondroﬁx provides an additional option for the
treatment of these lesions in the knee.
Figure 1. (A) Outerbridge Grade IV osteochondral defect of medial femoral
condyle. (B) 1511 mm Chondroﬁx Osteochonfral Allograft immediately
after implantation
Figure 3. Arthroscopic examination of intact Chondroﬁx Osteochondral
Allograft 25 months after implantation revealing smooth borders without
step-off (A,B).
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Purpose: We investigated histopathologically and immunohis-
tochemically effects of loading on cartilage repair in rat full-thickness
articular cartilage defects.
Methods: A total of 40 male 9-week-old Wistar rats were used. Full-
thickness articular cartilage defects were created over the capsule at the
loading portion in the medial condyle of the femur. Twenty rats were
randomly allocated into each of a loading group and non-loading group.
Twenty rats from these two groups were later randomly allocated to
each of 2 groups for evaluation at 1 and 2 weeks after surgery. At the
end of each period, the tissue of the defects were examined histo-
pathologically and immunohistochemically.
Results: In both groups at 1 and 2 weeks, the defects were ﬁlled with
mixture of granulation tissue and some remnants of hyaline cartilage.
The repair tissue were not stained with Toluidine blue in the both
groups. However, the adjacent articular cartilage to repair tissue in a
loading group were more strongly and thickly stained with Toluidine
blue than that in non-loading group. Strong staining of type I collagen
was observed in repair tissue of the both groups. The area stained with
type I collagen in non-loading group was smaller than that in loading
groups. However, apparent staining of type II collagenwas not detected
in any repair tissue of the both groups.
Conclusions: Non-weight bearing in the early phase of an articular
cartilage defect may be accompanied by a good tissue repair, althogh
non-weight bearing may decrease the function of adjacent normal
cartilage.Fig. 1. Histopathological and immunohistochemical staining of the repair
tissue.Sagittal sections of full-thickness articular cartilage defects in the
loading group (A-D, I-L) and non-loading group (E-H, M-P) at 1week (A-
D, E-H) and 2 weeks (I-L, M-P). The sections were stained with hema-
toxylin and eosin (A, E, I, M), Toluidine Blue (B, F, J, N) and immuno-
histochemical staining for type I collagen (C, G, K, O) and type II collagen
(D, H, L, P). Scale bar ¼ 500 mm.Cell Signaling
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DKK1, FRZB, GREM1 PREVENT IL1B INDUCED ARTICULAR CARTILAGE
DEGRADATION
L. Zhong, M. Karperien, J.N. Post. MIRA Inst. for BioMed. technology and
technical medicine, Enschede, Netherlands
Purpose: Osteoarthritis (OA) is a multifactorial disease characterized by
progressive degradation of articular cartilage leading to loss of joint
function. It affects several million people in the world. Currently there is
no cure for OA. In a subset of patients OA is associated with hyper-
trophic differentiation of articular chondrocytes. This process normally
occurs in the growth plate. Healthy articular cartilage is protected
against hypertrophy. Our group identiﬁed DKK1, FRZB (WNT antago-
nists) and GREM1 (BMP antagonist) as the natural brakes on hyper-
trophic differentiation and regulation of the maintenance of the
articular phenotype. Moreover, we previously demonstrated that
decreased production of DKK1, FRZB, GREM1 in human chondrocytes
has been associatedwith cartilage hypertrophy in OA. In this project, we
hypothesize that DKK1, FRZB, GREM1 are the gatekeepers for the
maintenance of homeostasis in articular cartilage. To prove this, we
investigated whether knockdown of DKK1, FRZB and GREM1 is sufﬁ-
cient to cause hypertrophic differentiation in healthy articular chon-
drocytes. Furthermore, we investigated the inﬂuence of catabolic
factors such as interleukin-1b (IL-1b) on the gene transcription levels of
DKK1, FRZB, GREM1. We found that the presence of DKK1, FRZB and
GREM1 is sufﬁcient to inhibit the catabolic effects of IL-1b.
Methods: Human primary chondrocytes (hCh) were isolated from
cartilage as described previously by our group. We isolated a neutral-
izing VhH antibody against DKK1 from a llama VhH library and used this
to block DKK1 activity in human primary chondrocytes cultured in
monolayer. The chondrocytes were cultured in chondrocyte pro-
liferation medium containing 5 mg/ml neutralizing antibody for 1 week.
Normal IgG served as a negative control. The neutralizing function of
the antibody was tested before use. Isolated chondrocytes were
exposed to 10ng/ml of recombinant human IL-1b, and 200ng/ml of each
of DKK1, FRZB, GREM1 (all recombinant proteins are from R&D sys-
tems). Cells received no medium refreshment after stimulation and
were cultured up to 48 hours.
Results: In the presence of recombinant DKK1 protein the mRNA
expressionof theWNT targetgeneAXIN2wasdownregulated. Inpresence
of both DKK1 and the DKK1 neutralizing antibody, AXIN2 mRNA was
upregulated suggesting that the WNT signal pathway activity was (re)
activated.MMP1, 3and13aswell asRUNX2wereupregulated in cellswith
DKK1 knockdown. The expression of Col10 could not be detected. This
